Secondary Logo

Journal Logo

Articles by Emmanouil Papasavvas

Hepatitis C virus modulates IgG glycosylation in HIV co-infected antiretroviral therapy suppressed individuals

Giron, Leila B.; Azzoni, Livio; Yin, Xiangfan; More

AIDS. 34(10):1461-1466, August 1, 2020.

Plasma and antibody glycomic biomarkers of time to HIV rebound and viral setpoint

Giron, Leila B.; Papasavvas, Emmanouil; Azzoni, Livio; More

AIDS. 34(5):681-686, April 1, 2020.

Concurrent measures of total and integrated HIV DNA monitor reservoirs and ongoing replication in eradication trials

Mexas, Angela M.; Graf, Erin H.; Pace, Matthew J.; More

AIDS. 26(18):2295-2306, November 28, 2012.

Delayed loss of control of plasma lipopolysaccharide levels after therapy interruption in chronically HIV-1-infected patients

Papasavvas, Emmanouil; Pistilli, Maxwell; Reynolds, Griffin; More

AIDS. 23(3):369-375, January 28, 2009.

Increased soluble vascular cell adhesion molecule-1 plasma levels and soluble intercellular adhesion molecule-1 during antiretroviral therapy interruption and retention of elevated soluble vascular cellular adhesion molecule-1 levels following resumption of antiretroviral therapy

Papasavvas, Emmanouil; Azzoni, Livio; Pistilli, Maxwell; More

AIDS. 22(10):1153-1161, June 19, 2008.

Lack of persistent drug-resistant mutations evaluated within and between treatment interruptions in chronically HIV-1-infected patients

Papasavvas, Emmanouil; Grant, Robert M; Sun, Junwei; More

AIDS. 17(16):2337-2343, November 7, 2003.